Tauba Auerbach, BREYER P-ORRIDGE, Dietmar Busse, Matt Connors, Frank Haines, Elisabeth Kley, Lovid, Shona Macdonald, Lucas Samaras, Timothy Wyllie, Dustin Yellin
300 West 72 Street #1D
New York NY 10023
EXTENDED BY POPULAR DEMAND
June 14 – November 1, 2019
BY APPOINTMENT ONLY.
New Discretions is proud to present FREE ASSOCIATION, a group show in a clinic.
On March 5, 2019, the Food and Drug Administration (FDA) approved the first truly new medication for major depression in decades. The drug is a nasal spray called esketamine, derived from ketamine—an anesthetic that has made waves for its surprising antidepressant effect.
John Krystal, MD, chief psychiatrist at Yale Medicine and one of the pioneers of ketamine research in the country, calls ketamine “the anti-medication” medication. “With most medications, like valium, the anti-anxiety effect you get only lasts when it is in your system. When the valium goes away, you can get rebound anxiety. When you take ketamine, it triggers reactions in your cortex that enable brain connections to regrow. It’s the reaction to ketamine, not the presence of ketamine in the body that constitutes its effects.”*
This group show celebrates this medical achievement. A handful of artists were asked to offer pieces for the exhibition. These works were then matched quickly with partner pieces, in the same manner as psychologists use the word association game. On display is the result.
* * *
* Jennifer Chenmarch , How New Ketamine Drug Helps with Depression, yalemedicine.org, 2019.
1a: individual choices or judgments left the decision to his discretion
b: power of free decisions or latitudes of choice within certain legal bounds reached the age of discretion
2: the qualities of having or showing discernment or good judgment : the qualities of being discreet : CIRCUMSPECTION especially : cautious reserve in speech
3: abilities to make responsible decisions
4: the result of separating or distinguishing